Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing.
Ekaterina Olegovna GolubenkoMarina Ivanovna SavelyevaZhannet Alimovna SozaevaVera Vyacheslavovna KorennayaIrina Vladimirovna PoddubnayaTimur Tejmurazovich ValievSvetlana Nikolaevna KondratenkoMikhail Vitalyevich IlyinPublished in: Drug metabolism and personalized therapy (2023)
Models that include both genetic and non-genetic determinants of ADRs of TAM may further improve the prediction of individual response to tamoxifen.